Cargando…

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

BACKGROUND: Natriuretic peptides are routinely quantified to diagnose heart failure (HF). Their concentrations are also elevated in atrial fibrillation (AF). To clarify their value in predicting future cardiovascular events, we measured natriuretic peptides in unselected patients with cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brady, Paul F., Chua, Winnie, Nehaj, Frantisek, Connolly, Derek L., Khashaba, Alya, Purmah, Yanish J. V., Ul‐Qamar, Muhammad J., Thomas, Mark R., Varma, Chetan, Schnabel, Renate B., Zeller, Tanja, Fabritz, Larissa, Kirchhof, Paulus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245805/ https://www.ncbi.nlm.nih.gov/pubmed/35112889 http://dx.doi.org/10.1161/JAHA.121.022833

Ejemplares similares

Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variables
por: Jawad-Ul-Qamar, Muhammad, et al.
Publicado: (2020)

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study
por: Chua, Winnie, et al.
Publicado: (2021)

Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
por: Chua, Winnie, et al.
Publicado: (2019)

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
por: Schnabel, Renate B., et al.
Publicado: (2018)

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions
por: Chua, Winnie, et al.
Publicado: (2023)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy
por: Pavlovic, Davor, et al.
Publicado: (2018)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Prognostic models for predicting incident or recurrent atrial fibrillation: protocol for a systematic review
por: Dretzke, Janine, et al.
Publicado: (2019)

An Introduction to Murine Models of Atrial Fibrillation
por: Riley, Genna, et al.
Publicado: (2012)

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial
por: Kirchhof, Paulus, et al.
Publicado: (2020)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers
por: Kotecha, Dipak, et al.
Publicado: (2018)

Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models
por: Dretzke, Janine, et al.
Publicado: (2020)

Integrated care in stroke survivors: When and how much?
por: Schnabel, Renate B., et al.
Publicado: (2020)

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC – AFNET 9
por: Fabritz, Larissa, et al.
Publicado: (2022)

Almanac 2015: atrial fibrillation research in Heart
por: Jawad-Ul-Qamar, Muhammad, et al.
Publicado: (2016)

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
por: Kany, Shinwan, et al.
Publicado: (2021)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset
por: Chua, Winnie, et al.
Publicado: (2019)

An automated system using spatial oversampling for optical mapping in murine atria. Development and validation with monophasic and transmembrane action potentials
por: Yu, Ting Yue, et al.
Publicado: (2014)

Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
por: Reyat, Jasmeet S., et al.
Publicado: (2020)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

LMNA Mutation in a Family with a Strong History of Sudden Cardiac Death
por: Keil, Laura, et al.
Publicado: (2022)

Systematic Analysis of Gene Expression Differences between Left and Right Atria in Different Mouse Strains and in Human Atrial Tissue
por: Kahr, Peter C., et al.
Publicado: (2011)

Biomarkers Associated With Aortic Valve Calcification: Should We Focus on Sex Specific Processes?
por: Peeters, Frederique E. C. M., et al.
Publicado: (2020)

Plasma Levels of Vascular Endothelial Growth Factor and Selected Hemostatic Parameters in Association With Treatment Response in Multiple Myeloma
por: Sokol, Juraj, et al.
Publicado: (2019)

Temporal irregularity quantification and mapping of optical action potentials using wave morphology similarity
por: O’Shea, Christopher, et al.
Publicado: (2020)

Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis
por: Al-Arkee, Shahd, et al.
Publicado: (2021)

Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice
por: Schnabel, Renate B, et al.
Publicado: (2022)

Cardiac Optogenetics and Optical Mapping – Overcoming Spectral Congestion in All-Optical Cardiac Electrophysiology
por: O’Shea, Christopher, et al.
Publicado: (2019)

COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria: A case report
por: Sokol, Juraj, et al.
Publicado: (2021)

Applying the ESC 2016, H(2)FPEF, and HFA‐PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population
por: Nikorowitsch, Julius, et al.
Publicado: (2021)

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans
por: Nehaj, Frantisek, et al.
Publicado: (2017)

G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis
por: Kuhlmann, Michael T., et al.
Publicado: (2006)

Outcomes of Patients with Newly Diagnosed Cardiac Myxoma: A Retrospective Multicentric Study
por: Nehaj, Frantisek, et al.
Publicado: (2018)

Phenotyping of Mice with Heart Specific Overexpression of A(2A)-Adenosine Receptors: Evidence for Cardioprotective Effects of A(2A)-Adenosine Receptors
por: Boknik, Peter, et al.
Publicado: (2018)

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation
por: Schnabel, Renate B, et al.
Publicado: (2017)

Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population
por: Salo, Perttu P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0tg9c6fihbbf208q0nfnphtqq5